Wall Street has faced heightened volatility in September as investors grappled with surging oil prices, elevated Treasury ...
HOUSTON, Sept. 22, 2026 (GLOBE NEWSWIRE)-- Orion Group Holdings, Inc. (NYSE: ORN) (the "Company" or "Orion"), a leading specialty construction company, today announced that management will participate ...
First targeted therapy approved in Canada for patients four years and older living with acquired hypothalamic obesity (HO) ...
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- newcleo plc (“newcleo” or the “Company”), a pioneer in advanced modular reactor ...
Archer Aviation (NYSE: ACHR) announced today that it plans to conduct public flights of its all-electric Midnight aircraft on Sept. 26–27 at the 2026 California International Air Show in Salinas, ...
XFLH Capital Corporation, a publicly traded special purpose acquisition company (the "Company"), today announced the signing of a non-binding letter-of-intent ("Letter of Intent") for a business ...
Rowan Saunders, President and Chief Executive Officer of Definity Financial Corporation (TSX: DFY), will participate in a fireside chat as part of the 25th Annual CIBC Eastern Institutional Investor ...
Oracle Life Sciences announced a partnership with Wipro Limited, a leading AI-powered technology services and consulting company to strengthen Wipro's pharmacovigilance (PV) service offering using ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Even Operations and Strategic PartnershipsNewly Acquired Azure Energy Has More Than $10 Million in Active Contracted Revenue Through 2027Management Focused on Expanding Revenue and EBITDA Through ...
ORLANDO, Fla., Sept. 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:NTRB) (NASDAQ:NTRBW) confirmed today that its outstanding warrants (NASDAQ:NTRBW) will expire on September 30, 2026 at 5PM ET as scheduled.
Novo is shaping a future beyond its Wegovy franchise as CEO Maziar Mike Doustdar looks to turn the drugmaker’s fortunes around.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results